4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-24-008929
CEO and CFO bought 4,100 shares at $13.03 ($53,423)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2024-03-04 | Purchase | +4,100 | $13.03 | $53,423 | 5,340,277 | D |
| Open-market purchases · 4,100 sh · avg $13.03 · $53,423 | |||||||
Loading xslF345X05/ownership.xml…